Nutritional implications of observed neurobehavioral disturbances and reduced gestation length in infants of mothers using selective serotonin reuptake inhibitors during pregnancy.
Vavasour
Elizabeth
E
D003863:Depression / Q000188:drug therapy / Q000503:physiopathology*; D004032:Diet; D005314:Embryonic and Fetal Development / Q000502:physiology*; D015525:Fatty Acids, Omega-3 / Q000502:physiology*; D005260:Female; D005865:Gestational Age; D006801:Humans; D018730:Infant Behavior; D007231:Infant, Newborn; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy / Q000503:physiopathology*; D011297:Prenatal Exposure Delayed Effects; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects*
D015525:Fatty Acids, Omega-3; D017367:Selective Serotonin Reuptake Inhibitors